For: | Mamori S, Nagatsuma K, Matsuura T, Ohkawa K, Hano H, Fukunaga M, Matsushima M, Masui Y, Fushiya N, Onoda H, Searashi Y, Takagi I, Tagiri H. Useful detection of CD147 (EMMPRIN) for pathological diagnosis of early hepatocellular carcinoma in needle biopsy samples. World J Gastroenterol 2007; 13(21): 2913-2917 [PMID: 17589939 DOI: 10.3748/wjg.v13.i21.2913] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v13/i21/2913.htm |
Number | Citing Articles |
1 |
Kyoshi Hanata, Noriko Yamaguchi, Kiwamu Yoshikawa, Yoshihiro Mezaki, Mitsutaka Miura, Shinsuke Suzuki, Haruki Senoo, Kazuo Ishikawa. Soluble EMMPRIN (extra-cellular matrix metalloproteinase inducer) stimulates the migration of HEp-2 human laryngeal carcinoma cells, accompanied by increased MMP-2 production in fibroblasts. Archives of Histology and Cytology 2007; 70(5): 267 doi: 10.1679/aohc.70.267
|
2 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_3-1
|
3 |
Yuan Cao, Hong-Wu Zhang. Recent advances in nano material-based application of liver neoplasms. Smart Materials in Medicine 2021; 2: 114 doi: 10.1016/j.smaim.2021.03.001
|
4 |
DONG DAI, WENGUI XU, JIANJING LIU, LEI ZHU, XIANG ZHU, XIAOYING MA. Safety and efficacy of a peripheral intravenous bolus of Licartin for the treatment of advanced hepatocellular carcinoma. Experimental and Therapeutic Medicine 2013; 6(6): 1417 doi: 10.3892/etm.2013.1321
|
5 |
Ningbo Sun, Huaijun Ji, Wei Wang, Qiang Zhu, Ming Cao, Qi Zang. Inhibitory effect of dexamethasone on residual Lewis lung cancer cells in mice following palliative surgery. Oncology Letters 2017; 13(1): 356 doi: 10.3892/ol.2016.5422
|
6 |
Xiaofeng Li, Xiaozhou Yu, Dong Dai, Xiuyu Song, Wengui Xu. The altered glucose metabolism in tumor and a tumor acidic microenvironment associated with extracellular matrix metalloproteinase inducer and monocarboxylate transporters. Oncotarget 2016; 7(17): 23141 doi: 10.18632/oncotarget.8153
|
7 |
Zhinan Chen, Huijie Bian, Jinliang Xing, Jianli Jiang, Yu Li, Xiaoling Yu, Li Wang, Xiangmin Yang, Chengong Liao. Primary Liver Cancer. 2012; : 299 doi: 10.1007/978-3-642-28702-2_10
|
8 |
Minghua Li, Li Deng, Jianbo Li, Weizhong Yuan, Xiaolong Gao, Jiong Ni, Hong Jiang, Jiaqi Zeng, Jie Ren, Peijun Wang. Actively Targeted Magnetothermally Responsive Nanocarriers/Doxorubicin for Thermochemotherapy of Hepatoma. ACS Applied Materials & Interfaces 2018; 10(48): 41107 doi: 10.1021/acsami.8b14972
|
9 |
Wei Mi, Wei Jia, Zhaobin Zheng, Jinglan Wang, Yun Cai, Wantao Ying, Xiaohong Qian. Surface glycoproteomic analysis of hepatocellular carcinoma cells by affinity enrichment and mass spectrometric identification. Glycoconjugate Journal 2012; 29(5-6): 411 doi: 10.1007/s10719-012-9420-3
|
10 |
Miroslaw Kornek, Yury Popov, Towia A. Libermann, Nezam H. Afdhal, Detlef Schuppan. Human T cell microparticles circulate in blood of hepatitis patients and induce fibrolytic activation of hepatic stellate cells. Hepatology 2011; 53(1): 230 doi: 10.1002/hep.23999
|
11 |
Li Jia, Huaxin Wang, Shuxian Qu, Xiaoyan Miao, Jianing Zhang. CD147 regulates vascular endothelial growth factor—A expression, tumorigenicity, and chemosensitivity to curcumin in hepatocellular carcinoma. IUBMB Life 2008; 60(1): 57 doi: 10.1002/iub.11
|
12 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 65 doi: 10.1007/978-3-319-26956-6_3
|
13 |
Lijuan Xiong, Carl Edwards, Lijun Zhou. The Biological Function and Clinical Utilization of CD147 in Human Diseases: A Review of the Current Scientific Literature. International Journal of Molecular Sciences 2014; 15(10): 17411 doi: 10.3390/ijms151017411
|